Purchase Order 75N92E20P00050

<p>The National Human Genome Research Institute awarded a purchase order to Biodiscovery, Inc. for $16,031.25 on December 18, 2017. Work is performed in Bethesda, Maryland. The order is for firm fixed price, with no small business set-aside. Ultimate completion is scheduled for December 29, 2017.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Eurofins Genomics LLC for $14,975.00 on December 13, 2016, with a firm fixed price for research studies. Place of performance is Bethesda, Maryland. The order was not set-aside and carries an ultimate completion date of January 11, 2021.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Bio Basic Canada Inc. for $1,834.68 on February 26, 2016. Performance is located in Bethesda, Maryland. The order carries a firm fixed price and no set-aside designation. Ultimate completion was scheduled for December 29, 2020.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Golden Helix Inc. for $8,745.00 on December 19, 2017, with completion by January 2, 2019. No set-aside was applied. Work is performed in Bethesda, Maryland. The order uses firm fixed-price pricing for commercial bioinformatics software licenses and analytical tools to support genomic data analysis and research at the institute.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Illumina, Inc. for $9,715.00 on October 19, 2017, with an ultimate completion date of November 18, 2017. Work is performed in North Bethesda, Maryland. The order is firm fixed price with no set-aside. The source does not specify the technical scope of materials or services procured under this purchase order.</p>

<p>The National Human Genome Research Institute (National Institutes of Health) awarded a purchase order to Illumina, Inc. valued at $208,735.16 on June 5, 2026, for firm fixed-price procurement with no set-aside designation. Work is performed in San Diego, California. The order is scheduled for ultimate completion by September 22, 2027.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Harper Health &amp; Science Communications LLC for $23,996.25 on April 30, 2018. Work is performed in North Bethesda, Maryland. The order is not set-aside. Ultimate completion is scheduled for May 29, 2018. Pricing is firm fixed price.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Enhanced Pharmacodynamics LLC on May 28, 2019, with a ceiling value of $25,000.00. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed price basis and carries no small business set-aside. The ultimate completion date is May 30, 2020. No solicitation citation or detailed scope statement appears in the award documentation.</p>

<p>The National Human Genome Research Institute issued a $24,926.45 delivery order to Illumina, Inc. on September 19, 2019, under a firm fixed-price structure.</p> <p>Place of performance is Bethesda, MD. The order was due for completion on September 2, 2020. No set-aside was applied to this delivery order.</p>

<p>The National Human Genome Research Institute awarded a purchase order to Biovisualization LLC for $19,999.20 on June 4, 2026 to modernize a web application supporting a telemedicine study. Work is performed in Bethesda, Maryland. The order is priced on a firm fixed price basis with an ultimate completion date of June 3, 2027.</p>